Remibrutinib (LOU064) treatment improves chronic spontaneous urticaria in patients irrespective of previous anti-IgE treatment: Phase 2b study results

被引：0
|
作者：
Metz, M. [1 ,2 ,3 ,4 ]
Greiner, A. [5 ,6 ]
Guduri, S. [7 ]
Leflein, J.
Haemmerle, S. [8 ]
Lheritier, K. [8 ]
Walsh, P. [9 ]
Nikolaev, I. [8 ]
Gimenez-Arnau, A. M. [10 ]
Maurer, M. [1 ,2 ,3 ,4 ]
机构：
[1] Inst Allergol, UCARE, Berlin, Germany
[2] Freie Univ, Berlin, Germany
[3] Humboldt Univ, Berlin, Germany
[4] Fraunhofer Inst Translat Med & Pharmacol ITMP, Allergol & Immunol, Berlin, Germany
[5] Allergy & Asthma Med Grp & Res Ctr, San Diego, CA USA
[6] Univ Calif San Diego, San Diego, CA USA
[7] Centricity Res Inc, Columbus, OH USA
[8] Novartis Pharma AG, Basel, Switzerland
[9] Novartis Ireland Ltd, Dublin, Ireland
[10] Univ Pompeu Fabra, Dept Dermatol, Hosp Mar IMIM, Barcelona, Spain
来源：
ALLERGY | 2023年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
000883
引用
收藏
页码：245 / 246
页数：2
相关论文
共 50 条
  • [31] Daily interferon alpha 2b and ribavirin combination therapy for chronic hepatitis C patients who have relaped or not responded to previous treatment: One year treatment results.
    Karasu, Z
    Gurakar, AO
    Jazzar, AS
    Emmett, C
    McMillon, GC
    Nour, BM
    Wright, HI
    GASTROENTEROLOGY, 2000, 118 (04) : A1455 - A1455
  • [32] Treatment of mild chronic hepatitis C with interferon α-2b:: results of a multi-centre randomized study in 80 patients
    Queneau, PE
    Osaer, F
    Bronowicki, JP
    Monnot, B
    Thiefin, G
    Bettinger, D
    Carbillet, JP
    Raabe, JJ
    Fratte, S
    Minello-Franza, A
    Bresson-Hadni, S
    Miguet, JP
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2001, 13 (02) : 143 - 147
  • [33] Results of a phase II trial of a combination of oral cytarabine ocfosfate (YNK01) and interferon α-2b for the treatment of chronic myelogenous leukemia patients in chronic phase
    F Maloisel
    A Guerci
    D Guyotat
    N Ifrah
    M Michallet
    J Reiffers
    G Tertain
    M Blanc
    F Bauduer
    J Brière
    JF Abgrall
    B Pegourie-Bandelier
    E Solary
    N Cambier
    D Coso
    JP Vilque
    M Delain
    JL Harousseau
    P Rousselot
    K Belhadj
    P Morice
    J Attal
    M Chabin
    C Chastang
    J Guilhot
    F Guilhot
    Leukemia, 2002, 16 : 573 - 580
  • [34] Results of a phase II trial of a combination of oral cytarabine ocfosfate (YNK01) and interferon α-2b for the treatment of chronic myelogenous leukemia patients in chronic phase
    Maloisel, F
    Guerci, A
    Guyotat, D
    Ifrah, N
    Michallet, M
    Reiffers, J
    Tertain, G
    Blanc, M
    Bauduer, F
    Brière, J
    Abgrall, JF
    Pegourie-Bandelier, B
    Solary, E
    Cambier, N
    Coso, D
    Vilque, JP
    Delain, M
    Harousseau, JL
    Rousselot, P
    Belhadj, K
    Morice, P
    Attal, J
    Chabin, M
    Chastang, C
    Guilhot, J
    Guilhot, F
    LEUKEMIA, 2002, 16 (04) : 573 - 580
  • [35] AOD9604, an orally active peptide for the treatment of obesity: Results of a phase 2b study
    Wittert, G
    Caterson, I
    Proietto, J
    Strauss, B
    Prins, J
    Stocks, A
    Vos, E
    Belyea, C
    Herd, C
    DIABETES, 2005, 54 : A440 - A441
  • [36] A randomized phase 2b study of peginterferon lambda-1a for the treatment of chronic HCV infection
    Muir, Andrew J.
    Arora, Sanjeev
    Everson, Gregory
    Flisiak, Robert
    George, Jacob
    Ghalib, Reem
    Gordon, Stuart C.
    Gray, Todd
    Greenbloom, Susan
    Hassanein, Tarek
    Hillson, Jan
    Horga, Maria Arantxa
    Jacobson, Ira M.
    Jeffers, Lennox
    Kowdley, Kris V.
    Lawitz, Eric
    Lueth, Stefan
    Rodriguez-Torres, Maribel
    Rustgi, Vinod
    Shemanski, Lynn
    Shiffman, Mitchell L.
    Srinivasan, Subasree
    Vargas, Hugo E.
    Vierling, John M.
    Xu, Dong
    Lopez-Talavera, Juan C.
    Zeuzem, Stefan
    JOURNAL OF HEPATOLOGY, 2014, 61 (06) : 1238 - 1246
  • [37] Efficacy and safety of omalizumab for the treatment of refractory chronic spontaneous urticaria in Japanese patients: Subgroup analysis of the phase 3 POLARIS study
    Hide, Michihiro
    Igarashi, Atsuyuki
    Yagami, Akiko
    Chinuki, Yuko
    Inomata, Naoko
    Fukunaga, Atsushi
    Kaiser, Guenther
    Wang, Junyi
    Matsushima, Soichiro
    Greenberg, Steven
    Khalil, Sam
    ALLERGOLOGY INTERNATIONAL, 2018, 67 (02) : 243 - 252
  • [38] Analysis of HBV genotype association to bepirovirsen treatment response in patients with chronic HBV infection (Phase 2b B-Clear study)
    Bouquet, Jerome
    Elston, Robert
    Yates, Phil
    You, Shihyun
    Youssef, Amir
    Nader, Ahmed
    Cremer, Jennifer
    Quinn, Geoff
    Campbell, Fiona
    Paff, Melanie
    Theodore, Dickens
    JOURNAL OF HEPATOLOGY, 2023, 78 : S1154 - S1155
  • [39] Analysis of HBV genotype association to bepirovirsen treatment response in patients with chronic HBV infection (Phase 2b B-Clear study)
    Bouquet, J.
    Elston, R.
    Yates, P.
    You, S.
    Youssef, A. S.
    Nader, A.
    Cremer, J.
    Milano, T.
    Quinn, G.
    Campbell, F.
    Paff, M.
    Theodore, D.
    DIGESTIVE AND LIVER DISEASE, 2025, 57 : S26 - S27
  • [40] Daily use of consensus interferon for chronic hepatitis C among patients who had relapsed or not responded to previous treatment with alpha interferon 2b: One year treatment results.
    Karasu, Z
    Gurakar, AO
    Jazzar, AS
    Emmett, C
    Hulagu, S
    Balkan, M
    Nour, BM
    Wright, HI
    GASTROENTEROLOGY, 2000, 118 (04) : A1455 - A1455
12345